{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:08:21Z","timestamp":1756166901532,"version":"3.44.0"},"reference-count":10,"publisher":"SMC Media","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>A 74-year-old patient anticoagulated with rivaroxaban for chronic atrial fibrillation presented to the emergency department with acute lumbar pain with progressive weakness of the lower limbs and inability to stand up. No previous trauma was reported. Neurological examination was consistent with a complete spinal cord syndrome at the level of T6. Magnetic resonance imaging showed the presence of spinal cord compression associated with signs of extensive intramedullary inflammation secondary to a haematoma. The patient underwent thoracic laminectomy with evacuation of an intradural haematoma. No intraoperative complications were described, but no clinical improvement had been achieved 15 days after the surgical intervention.<\/jats:p>","DOI":"10.12890\/2021_002593","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T10:11:37Z","timestamp":1621937497000},"source":"Crossref","is-referenced-by-count":2,"title":["Spinal Cord Compression Secondary to a Spontaneous Spinal Haematoma in a Patient Newly Treated with Rivaroxaban"],"prefix":"10.12890","volume":"8","author":[{"given":"Javier","family":"Guerrero-Ni\u00f1o","sequence":"additional","affiliation":[{"name":"Service des Urgences, H\u00f4pitaux Universitaires de Strasbourg, Strasbourg, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"De Cesaris","sequence":"additional","affiliation":[{"name":"Service des Urgences, H\u00f4pitaux Universitaires de Strasbourg, Strasbourg, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Jannot","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne, Diab\u00e8te et Maladies M\u00e9taboliques, H\u00f4pitaux Universitaires de Strasbourg, Strasbourg, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel","family":"Lorenzo Villalba","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne, Diab\u00e8te et Maladies M\u00e9taboliques, H\u00f4pitaux Universitaires de Strasbourg, Strasbourg, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10397","published-online":{"date-parts":[[2021,5,10]]},"reference":[{"key":"10.12890\/2021_002593_ref1","doi-asserted-by":"crossref","unstructured":"<li>Testa S, Legnani C, Antonucci E, Paoletti O, Dellanoce C, Cosmi B, et al; Coordinator of START2-Register. Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants. <em>J Thromb Haemost<\/em> 2019;<strong>17<\/strong>(7):1064\u20131072.<\/li>","DOI":"10.1111\/jth.14457"},{"key":"10.12890\/2021_002593_ref2","doi-asserted-by":"crossref","unstructured":"<li>Schulman S, Kearon C; Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. <em>J Thromb Haemost<\/em> 2005;<strong>3<\/strong>(4):692\u2013694.<\/li>","DOI":"10.1111\/j.1538-7836.2005.01204.x"},{"key":"10.12890\/2021_002593_ref3","doi-asserted-by":"crossref","unstructured":"<li>Beyer Westendorf J, Forster K, Pannach S, Ebertz F, Gelbricht V, Thieme C, et al. Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the <li>Dresden NOAC registry. <em>Blood<\/em> 2014;<strong>124<\/strong>:955\u2013962.<\/li>","DOI":"10.1182\/blood-2014-03-563577"},{"key":"10.12890\/2021_002593_ref4","doi-asserted-by":"crossref","unstructured":"<li>Fiani B, Jarrah R, Fiani NJ, Runnels J. Spontaneous cervical epidural hematoma: insight into this occurrence with case examples. <em>Surg Neurol Int<\/em> 2021;<strong>12<\/strong>:79.<\/li>","DOI":"10.25259\/SNI_15_2021"},{"key":"10.12890\/2021_002593_ref5","doi-asserted-by":"crossref","unstructured":"<li>Nguyen SN, Ruegger MC, Salazar E, Dreucean D, Tatara AW, Donahue KR. Evaluation of anti-Xa apixaban and rivaroxaban levels with respect to known doses in relation to major bleeding events. <em>J Pharm Pract<\/em> 2021 Apr 12:8971900211009075.<\/li>","DOI":"10.1177\/08971900211009075"},{"key":"10.12890\/2021_002593_ref6","unstructured":"<li>Goodman SG, Wojdyla DM, Piccini JP, et al. Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation). <em>J Am Coll Cardiol<\/em> 2014;<strong>63<\/strong>(9):891\u2013900. <\/li>"},{"key":"10.12890\/2021_002593_ref7","doi-asserted-by":"crossref","unstructured":"<li>Massicotte A. A practice tool for the new oral anticoagulants [published correction appears in Can Pharm J (Ott). 2014;147(5):319]. <em>Can Pharm J<\/em> (Ott) 2014;<strong>147<\/strong>(1):25\u201332. <\/li>","DOI":"10.1177\/1715163513513869"},{"key":"10.12890\/2021_002593_ref8","doi-asserted-by":"crossref","unstructured":"<li>Diener H-C, Aisenberg J, Ansell J, Atar D, Breithardt G, Eikelboom J, et al. Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1. <em>Eur Heart J<\/em> 2017;<strong>38<\/strong>(12):852\u2013859.<\/li>","DOI":"10.1093\/eurheartj\/ehv643"},{"key":"10.12890\/2021_002593_ref9","doi-asserted-by":"crossref","unstructured":"<li>By the 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for Potentially Inappropriate Medication Use in Older Adults. <em>J Am Geriatr Soc<\/em> 2019;<strong>67<\/strong>(4):674\u2013694.","DOI":"10.1111\/jgs.15767"},{"key":"10.12890\/2021_002593_ref10","unstructured":"<\/li>"}],"container-title":["European Journal of Case Reports in Internal Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.ejcrim.com\/index.php\/EJCRIM\/article\/download\/2593\/2676","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ejcrim.com\/index.php\/EJCRIM\/article\/download\/2593\/2677","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ejcrim.com\/index.php\/EJCRIM\/article\/download\/2593\/2677","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T13:50:09Z","timestamp":1756129809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ejcrim.com\/index.php\/EJCRIM\/article\/view\/2593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,10]]},"references-count":10,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.12890\/2021_002593","relation":{"has-manifestation":[{"id-type":"other","id":"1-71-2593-g2676","asserted-by":"subject"},{"id-type":"other","id":"1-71-2593-g2677","asserted-by":"subject"}],"is-part-of":[{"id-type":"other","id":"1-71","asserted-by":"subject"}]},"ISSN":["2284-2594"],"issn-type":[{"type":"electronic","value":"2284-2594"}],"subject":[],"published":{"date-parts":[[2021,5,10]]},"article-number":"17"}}